May 2008
 
EW WEEK Vol. 13 No. 13
· Pfizer drops trials of NicOx glaucoma drug
· RegenRx awarded patent in Hong Kong
· FDA grants request to expand Neovista’s CABERNET trial
· Bepreve demonstrates efficacy in Phase III trial

[Valid RSS]View this Issue

Would you like to receive EyeWorld Week?

 
Monthly Poll

Do you believe glistenings can become severe enough to affect a patient’s visual acuity?

Yes
No



[ Results | Polls ]

Votes:14|Comments:0
 
Resources

Ophthalmologists

Practice Managers

Consumers


NYU-ASCRS Podcasting


EyeSpaceMD

 
 
Search :  
  
     
Advanced Search
     
Managing Ocular Surface Disease in Glaucoma Patients


Read it Online | Download a Copy

By taking this online CME test, I certify that I am a physician licensed to practice in the United States and that my answers have been completed individually and are based on personal knowledge gains from review of the written material.
I understand I must answer 80% of the questions correctly to receive credit. If I do not answer at least 80% of the questions correctly, I will have the opportunity to review the material and take the test again.





Copyright © 1997-2008 EyeWorld News Service


Visit EyeWorld.mobi for a PDA optimized experience